New grad roles at Lycia Therapeutics
Lycia Therapeutics is a private, clinical-stage biotechnology company developing LYTAC and cataLYTAC protein degraders. Its platform targets disease-causing extracellular proteins for lysosomal degradation.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 11–50 employees
- Stage
- Series D
- Open roles
- 4
No current roles
Check back soon.
Get new Lycia Therapeutics new grad roles by email
Free account. Get new Lycia Therapeutics new grad roles by email or push the minute they post.

